Independent Research on Mutual Funds, Stocks & IPOs for Indian Investors

Goldline Pharmaceutical Limited, incorporated in 2004 and based in Nagpur, Maharashtra, is a pharmaceutical marketing company operating entirely on an asset-light, third-party contract manufacturing model. Markets products under the proprietary 'Goldline' brand across 5 segments: Goldline Pharma (specialties including orthopedics, ENT, gastroenterology, neurology, urology), Goldline Ortho, Goldline Neuro, Goldline Cardiac, and Goldline Derma. Works with 15 contract manufacturers and distributes through 8 distributors. Revenue ₹28.06 Cr (FY25) vs ₹23.57 Cr (FY24), PAT ₹2.83 Cr (FY25) vs ₹1.81 Cr (FY24). Promoters hold 79.70% pre-IPO.